Belmont, CA, United States of America

Carol A Christopher

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 464(Granted Patents)


Location History:

  • Belmont, CA (US) (2005 - 2015)
  • Palo Alto, CA (US) (2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carol A Christopher

Introduction

Carol A Christopher is a notable inventor based in Belmont, CA (US). She has made significant contributions to the field of drug therapy, holding a total of 7 patents. Her work focuses on methods and devices that enhance the effectiveness of therapeutic drug delivery.

Latest Patents

One of her latest patents is titled "Methods and devices for providing prolonged drug therapy." This invention provides methods and devices for maintaining a desired therapeutic drug effect over an extended therapy period. Specifically, it includes oral dosage forms that release drugs within the gastrointestinal tract at an ascending release rate over an extended time period. Additionally, these dosage forms may comprise an immediate-release dose of the drug, ensuring a more effective treatment regimen.

Career Highlights

Carol A Christopher has had a distinguished career, working with Alza Corporation, a company known for its innovative drug delivery systems. Her expertise in pharmaceutical technology has led to advancements that benefit patients requiring prolonged drug therapy.

Collaborations

Throughout her career, she has collaborated with talented individuals such as Suneel K Gupta and Diane R Guinta. These collaborations have fostered an environment of innovation and creativity, contributing to the success of her projects.

Conclusion

Carol A Christopher's contributions to drug therapy through her patents and collaborations highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to impact the way therapeutic drugs are delivered, improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…